D-0224-2025 Class II Ongoing

Recalled by AvKARE — Pulaski, TN

FDA drug recall D-0224-2025 was initiated by AvKARE on Jan 21, 2025 and is designated Class II. Reason for recall: Out of Specification for Dissolution The recall status is ongoing. Affected quantity: 341 cartons.

Recall details

Product Type
Drugs
Report Date
Feb 19, 2025
Initiation Date
Jan 21, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
341 cartons

Product description

Irbesartan Tablets USP, 300 mg, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-442-15

Reason for recall

Out of Specification for Dissolution

Distribution pattern

Nationwide in the USA

Code information

Lot 45279, Exp 03/31/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0224-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0224-2025. Report a data issue: hello@regdatalab.com.